Document is current

Article History

Received: 10 April 2025

Accepted: 16 July 2025

First Online: 27 August 2025

Declarations

:

: The study was approved by the Institutional Review Board in accordance with ethical guidelines and registered in a clinical trial registry. Due to the retrospective nature of the study, the requirement for informed consent was waived, and patient participation was facilitated through an opt-out approach.

: All authors have reviewed the final version of the manuscript and consent to its publication.

: The authors declare no actual or potential conflicts of interest regarding this work. Although some of the authors have received honoraria, research funding, or scholarship donations from various pharmaceutical companies and other organizations outside of the submitted work, none of these constitute actual or potential conflicts of interest. T.F. received honoraria from AstraZeneca, Boehringer-Ingelheim, Chugai Pharm, Eli Lilly, Kyorin Pharm, MSD, Novartis Pharma, Ono Pharm, Taiho Pharm, and Takeda Parm outside of the submitted work. Y.I. received honoraria from AbbVie, Daiichi-Sankyo, Eli Lilly, Kyowa Kirin, MSD, and Pfizer outside of the submitted work. T.K. received honoraria from Asahi Kasei, AstraZeneca, Boehringer-Ingelheim, Chugai Pharm, Eli Lilly, Taiho Pharm, and Eisai outside of the submitted work. K.U. received honoraria from AstraZeneca, Boehringer-Ingelheim, Chugai Pharm, MSD, and Nippon Kayaku outside of the submitted work. R.S. received honoraria from m Chugai Pharm, Daiichi Sankyo, MSD, Ono Pharm, and Taiho Pharma outside of the submitted work. H.M. has received honoraria from Daiichi-Sankyo and Ono Pharm, research funding from Astelas-Amgen Biopharma, Bayer, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Incite, Novartis, Ono Pharm, Pfizer, and Rakuten-Medical, and scholarship donations from Bayer, Chugai, Daiichi-Sankyo, Eisai, Kyowa-Kirin, Lilly, Ono Pharmaceutical, Pfizer, Taiho Pharma, and Takeda outside of the submitted work. These organizations had no role in the design, conduct, or reporting of this work. All other authors declare that they have no competing interests.